PATENT CLAIM ANALYSIS

Application Number: 15768352
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["424", "450000"]

Abstract:
Irinotecan phospholipid liposomes with improved storage stability are provided, with related methods of treatment and manufacture. The irinotecan liposomes can have reduced formation of lyso-phosphatidylcholine (lyso-PC) during storage, and prior to administration to a patient.

Claim (Index 18):
The liposomal irinotecan composition of  claim 1 , forming less than 1 mg/mL lyso-phosphatidylcholine (lyso-PC) after 6 months of storage at about 4\u00b0 C.

Metadata:
- Claim Count in Document: 77.0
- Percentile: 91.0
- Lexical Diversity: 1.24242
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15798287', '14395345', '15340761', '15241128', '14965140']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7515765256788255
- 35 USC 102 Novelty (BERT): 0.5515279659460507
- Combined Prediction Score: 0.731571669705548
- Mean Citation Score: 395.737634
- Max Citation Score: 416.47427000000016
- Similarity Product: 268.0522429908902

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test